Table 4.
Ratios of rate of event evaluations in the RM-ON group vs. the RM-OFF group, expressed in terms of PS-matched, adjusted/unadjusted hazard ratios between study groups.
| Variable | PS-matched | Unmatched | |
|---|---|---|---|
| Univariate HR (CI); p |
Multivariate HR (CI); p |
Multivariate HR (CI); p |
|
| All events | |||
| Remote monitoring | 2.22 (1.15–4.30); p = 0.017 | 2.53 (1.32–4.86); p = 0.005 | 2.57 (1.39–4.74); p = 0.002 |
| Adjusting variables | |||
| CAD | 0.54 (0.21–1.41); p = 0.43 | 0.82 (0.38–1.76); p = 0.60 | |
| Hypertension | 3.81 (2.09–6.94); p < 0.0001 | 2.89 (1.64–5.10); p = 0.0002 | |
| Asymptomatic events | |||
| Remote monitoring | 4.58 (1.64–12.76); p = 0.0003 | 4.28 (1.52–11.96); p = 0.006 | 4.58 (1.78–11.78); p = 0.002 |
| Adjusting variables | |||
| CAD | 0.64 (0.19–2.12); p = 0.47 | 1.05 (0.39–2.86); p = 0.60 | |
| Hypertension | 2.55 (1.15–5.64); p = 0.02 | 1.94 (0.93–4.22); p = 0.07 | |
| Events leading to pacemaker implantation | |||
| Remote monitoring | 2.18 (0.89–5.33); p = 0.08 | 2.82 (1.77–6.77); p = 0.02 | 2.31 (1.08–4.95); p = 0.03 |
| Adjusting variables | |||
| CAD | 0.75 (0.29–1.98); p = 0.57 | 0.50 (0.16–1.57); p = 0.23 | |
| Hypertension | 3.13 (1.51–6.46); p = 0.002 | 4.32 (1.99–9.38); p = 0.0002 | |
CAD, coronary artery disease; CI, confidence interval; HR, hazard ratio; PS, propensity score; RM, remote monitoring.